|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12P 21/08 | |
| A61P 35/00 | |||
| A61K 39/395 | |||
| C07K 16/28 | |||
| C07K 16/30 |
| (11) | Number of the document | 2134854 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08726810.8 |
| Date of filing the European patent application | 2008-03-14 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/003369 |
| Date | 2008-03-14 |
| (87) | Number | WO 2008/115404 |
| Date | 2008-09-25 |
| (30) | Number | Date | Country code |
| 918084 P | 2007-03-15 | US |
| (72) |
CAVENEE, Webster, US
FURNARI, Frank, US
JOHNS, Terrance, Grant, AU
SCOTT, Andrew, AU
|
| (73) |
Ludwig Institute for Cancer Research Ltd.,
605 Third Avenue, New York, NY 10158,
US
|
| (54) | TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |
| TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |